- Home
- U vs QGEN Comparison
U vs QGEN Comparison
Compare U & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- U
- QGEN
- Stock Information
- Founded
- U 2004
- QGEN 1986
- Country
- U United States
- QGEN Netherlands
- Employees
- U N/A
- QGEN N/A
- Industry
- U Retail: Computer Software & Peripheral Equipment
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- U Technology
- QGEN Health Care
- Exchange
- U Nasdaq
- QGEN Nasdaq
- Market Cap
- U 7.7B
- QGEN 9.1B
- IPO Year
- U 2020
- QGEN 1996
- Fundamental
- Price
- U $19.23
- QGEN $40.71
- Analyst Decision
- U Buy
- QGEN Buy
- Analyst Count
- U 13
- QGEN 9
- Target Price
- U $23.88
- QGEN $49.79
- AVG Volume (30 Days)
- U 9.0M
- QGEN 1.6M
- Earning Date
- U 05-07-2025
- QGEN 05-07-2025
- Dividend Yield
- U N/A
- QGEN 3.24%
- EPS Growth
- U N/A
- QGEN N/A
- EPS
- U N/A
- QGEN 0.38
- Revenue
- U $1,813,255,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- U N/A
- QGEN $4.74
- Revenue Next Year
- U $9.97
- QGEN $6.52
- P/E Ratio
- U N/A
- QGEN $106.96
- Revenue Growth
- U N/A
- QGEN 0.66
- 52 Week Low
- U $13.90
- QGEN $37.63
- 52 Week High
- U $30.88
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- U 46.47
- QGEN 51.47
- Support Level
- U $18.12
- QGEN $38.97
- Resistance Level
- U $19.92
- QGEN $43.88
- Average True Range (ATR)
- U 1.52
- QGEN 1.53
- MACD
- U 0.11
- QGEN 0.18
- Stochastic Oscillator
- U 66.95
- QGEN 44.87
About U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).